Revenue
2020
2021
2022
2023
2024
2025
Vetoquinol SA (VETO)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | €525.7M | €539.2M | €529.3M | €539.8M | €521.3M | €427.5M |
| Research & development | €2.1M | €2.4M | €1.8M | €2.8M | — | — |
| Operating expenses | €314.1M | €311.2M | €294.9M | €295.9M | — | — |
| Operating income | €78.3M | €77.3M | €74.3M | €74.0M | €86.3M | €37.1M |
| Operating margin | 14.89% | 14.34% | 14.03% | 13.71% | 16.55% | 8.68% |
| EBITDA | €116.0M | €114.1M | €112.3M | €116.2M | — | — |
| EBITDA margin | 22.07% | 21.16% | 21.22% | 21.53% | — | — |
| Net income | €57.3M | €58.7M | €55.6M | €48.0M | €48.0M | €19.2M |
| Net profit margin | 10.91% | 10.88% | 10.50% | 8.89% | 9.21% | 4.50% |
| Basic EPSper basic share | €4.94 | €4.98 | €4.70 | €4.06 | €5.31 | €1.63 |
| Diluted EPSper diluted share | €4.94 | €4.98 | €4.70 | €4.06 | €5.33 | €1.63 |